Physician profile
Brian Allen
NPI 1073975025
$869.17
in general payments reported to CMS, 2019-2025
8 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $36.86 · 2023: $137 · 2024: $351 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668 · Education: $55.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.70 |
| Education | $55.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $626.31 | 2021-2025 | Arikayce |
| Astrazeneca Pharmaceuticals Lp | $70.37 | 2024 | Breztri, Airsupra, Tezspire |
| Electromed, INC. | $46.50 | 2025 | Smartvest |
| Glaxosmithkline, LLC. | $36.36 | 2023-2024 | Trelegy Ellipta |
| Baxter Healthcare | $27.33 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Xeris Pharmaceuticals, INC. | $21.78 | 2024 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.62 | 2023 | Ofev |
| Genzyme Corporation | $18.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.